F

Fenway Health | The Fenway Institute

Research site

(Unclaimed)

Location

1340 Boylston Street, Boston, Massachusetts, United States of America

Site insights

Top conditions

Top treatments

Emtricitabine

Lenacapavir

Truvada

fluorouracil

PrEP

MK-8527-007

imiquimod

Tenofovir

TDF

MK-8527

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 38 total trials

SmartSteps: A Context-Aware, PrEP Adherence Intervention for Individuals With Substance Use Disorder

This is a single-arm, observational study of HIV-negative MSM with substance use disorder. Those who meet pre-screening criteria will attend a Screen...

Enrolling

Substance Use

Adherence, Treatment

Drug: Descovy or Truvada

Device: Beiwe

Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) in Prevention of HIV in Cisgender Women in the United States (HPTN 102) (PURPOSE 3)

The goal of this clinical study is to look at how lenacapavir (LEN) passes through the body and to assess the safety of LEN and emtricitabine/tenofov...

Active, not recruiting

Pre-Exposure Prophylaxis of HIV Infection

Drug: Lenacapavir Injection

Drug: Lenacapavir Tablet

Locations recently updated

Study of Lenacapavir for HIV Pre-Exposure Prophylaxis in People Who Are at Risk for HIV Infection (PURPOSE 2)

The goal of this study is to evaluate the efficacy of the study drugs, lenacapavir (LEN) in preventing HIV infection, in participants ≥ 16 years of a...

Active, not recruiting

Pre-Exposure Prophylaxis of HIV Infection

Drug: Sub-cutaneous (SC) Lenacapavir (LEN)

Drug: PTM Oral LEN